Taiwan

With a strong growth market for drug development, dense population, and a universal healthcare system, Taiwan is an ideal location for clinical trials.

George Clinical In Taiwan

Taiwan is one of George Clinical’s fastest growing Asian hubs.

With a strong growth market for drug development, dense population, and a universal healthcare system, Taiwan is an ideal location for clinical trials. George Clinical’s on the ground clinical team leader oversees a number of our CRAs and CTAs in delivering customer projects across Taiwan. The Center for Drug Evaluation (CDE) was established by the Ministry of Health and Welfare (MOHW) to assist the Taiwan Food and Drug Administration (TFDA) in the technical review of new drugs, medical devices and clinical trials to fulfil regulatory requirements.

The MOHW regularly accredits sites for clinical trial conduct, where the certificate is valid for four years. There are 128 qualified sites for conducting clinical trials in Taiwan. Known centers for excellence include the National Taiwan University Hospital, which currently runs over 600 clinical trials, including 43 Phase I clinical trials; and Chang Gung Memorial Hospital, which currently runs over 500 clinical trials. There is strong government support for clinical trials.

What are the benefits of conducting clinical trials in Taiwan?

  • Taiwan is a strong growth market for drug development
  • Approximately 80% of CT in Taiwan are multinational trials
  • Almost 100% of Taiwanese nations are covered by the National health Insurance (NHI) program, which provides universal quality healthcare to its population at an affordable cost
  • Clinical Trail Notification and c-IRB Mechanisms provide fast study start-up timeline

What are the prevalent diseases in Taiwan?

  1. Cancer
  2. Heart disease
  3. Pneumonia
  4. Cerebrovascular
  5. Diabetes mellitus
  6. Chronic lower respiratory disease
  7. Hypertension
  8. Kidney disease
  9. Chronic liver disease

Staff Experience in Taiwan

Cardiovascular 50%

Central Nervous System 50%

Medical Devices 25%

Endocrinology 50%

Oncology 75%

Respiratory 50%

Nephrology 25%

Contact

George Clinical Address:
4F, No. 200, Sec. 1, Keelung Road,
Taipei 110 Taiwan

Details

Population 23.5 million
Number of Personnel 5
Official Language Mandarin Chinese (official), Taiwanese (Min), Hakka, Aboriginal dialects
Hospital Records Language English and Traditional Chinese
Electronic Hospital Records All Taiwanese hospitals utilize a standard form of electronic medical records
Site Network Only accredited teaching hospitals are able to carry out human clinical trials. There are approximately 128 qualified clinical trial sites in Taiwan
In-country services Clinical Operations
Regulatory Services
GDP – per capita (US $) $24,318
George Clinical

1-901-259-0888

Profits from George Clinical support the work of The George Institute for Global Health.

Join our Mailing List

Add George Clinical to your network